4.6 Article

Early Increase and Late Decrease of Purkinje Cell Dendritic Spine Density in Prion-Infected Organotypic Mouse Cerebellar Cultures

Journal

PLOS ONE
Volume 8, Issue 12, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0081776

Keywords

-

Funding

  1. PrioNet Canada [G119990412]
  2. Alberta Prion Research Institute [G224200029]

Ask authors/readers for more resources

Prion diseases are infectious neurodegenerative diseases associated with the accumulation of protease-resistant prion protein, neuronal loss, spongiform change and astrogliosis. In the mouse model, the loss of dendritic spines is one of the earliest pathological changes observed in vivo, occurring 4-5 weeks after the first detection of protease-resistant prion protein in the brain. While there are cell culture models of prion infection, most do not recapitulate the neuropathology seen in vivo. Only the recently developed prion organotypic slice culture assay has been reported to undergo neuronal loss and the development of some aspects of prion pathology, namely small vacuolar degeneration and tubulovesicular bodies. Given the rapid replication of prions in this system, with protease-resistant prion protein detectable by 21 days, we investigated whether the dendritic spine loss and altered dendritic morphology seen in prion disease might also develop within the lifetime of this culture system. Indeed, six weeks after first detection of protease-resistant prion protein in tga20 mouse cerebellar slice cultures infected with RML prion strain, we found a statistically significant loss of Purkinje cell dendritic spines and altered dendritic morphology in infected cultures, analogous to that seen in vivo. In addition, we found a transient but statistically significant increase in Purkinje cell dendritic spine density during infection, at the time when protease-resistant prion protein was first detectable in culture. Our findings support the use of this slice culture system as one which recapitulates prion disease pathology and one which may facilitate study of the earliest stages of prion disease pathogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Aβ seeds and prions: How close the fit?

Jay Rasmussen, Mathias Jucker, Lary C. Walker

PRION (2017)

Article Multidisciplinary Sciences

Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease

Jay Rasmussen, Jasmin Mahler, Natalie Beschorner, Stephan A. Kaeser, Lisa M. Haesler, Frank Baumann, Sofie Nystrom, Erik Portelius, Kaj Blennow, Tammaryn Lashley, Nick C. Fox, Diego Sepulveda-Falla, Markus Glatzel, Adrian L. Oblak, Bernardino Ghetti, K. Peter R. Nilsson, Per Hammarstrom, Matthias Staufenbiel, Lary C. Walker, Mathias Jucker

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Letter Clinical Neurology

Infectious prions do not induce Aβ deposition in an in vivo seeding model

Jay Rasmussen, Susanne Krasemann, Hermann Altmeppen, Petra Schwarz, Juliane Schelle, Adriano Aguzzi, Markus Glatzel, Mathias Jucker

ACTA NEUROPATHOLOGICA (2018)

Article Neurosciences

The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity

B. V. Foroutanpay, J. Kumar, S. G. Kang, N. Danaei, D. Westaway, V. L. Sim, S. Kar

NEUROSCIENCE (2018)

Article Immunology

In silico identification and high throughput screening of antigenic proteins as candidates for a Mannheimia haemolytica vaccine

Cassidy L. Klima, Rahat Zaheer, Shaun R. Cook, Jay Rasmussen, Trevor W. Alexander, Andrew Potter, Steve Hendrick, Tim A. McAllister

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2018)

Review Biochemistry & Molecular Biology

POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research

Hailey Pineau, Valerie Sim

BIOMOLECULES (2020)

Article Neurosciences

Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life

Ruth E. Uhlmann, Christine Rother, Jay Rasmussen, Juliane Schelle, Carina Bergmann, Emily M. Ullrich Gavilanes, Sarah K. Fritschi, Anika Buehler, Frank Baumann, Angelos Skodras, Rawaa Al-Shaana, Natalie Beschorner, Lan Ye, Stephan A. Kaeser, Ulrike Obermueller, Soren Christensen, Fredrik Kartberg, Jeffrey B. Stavenhagen, Jens-Ulrich Rahfeld, Holger Cynis, Fang Qian, Paul H. Weinreb, Thierry Bussiere, Lary C. Walker, Matthias Staufenbiel, Mathias Jucker

NATURE NEUROSCIENCE (2020)

Review Virology

Exposure Risk of Chronic Wasting Disease in Humans

Satish K. Nemani, Jennifer L. Myskiw, Lise Lamoureux, Stephanie A. Booth, Valerie L. Sim

VIRUSES-BASEL (2020)

Review Biochemistry & Molecular Biology

From Cell Culture to Organoids-Model Systems for Investigating Prion Strain Characteristics

Hailey Pineau, Valerie L. Sim

Summary: This review discusses various cell models used to study prion diseases, ranging from simple cell cultures to complex neurospheres, organoids, and organotypic slice cultures. The advantages and disadvantages of each system are highlighted, with special consideration given to the importance of strains when choosing a model and interpreting results.

BIOMOLECULES (2021)

Article Clinical Neurology

An early proinflammatory transcriptional response to tau pathology is age-specific and foreshadows reduced tau burden

Jay Rasmussen, Adam D. Ewing, Liviu-Gabriel Bodea, Gabriela O. Bodea, Marla Gearing, Geoffrey J. Faulkner

Summary: Age is a significant risk factor for neurodegenerative diseases, affecting the onset of pathology and molecular responses. Research shows that in mice injected with tau pathology at 12 months of age, the burden of hyperphosphorylated tau pathology is moderately reduced, with higher expression of inflammation-related genes.

BRAIN PATHOLOGY (2022)

Article Microbiology

Asymmetric-flow field-flow fractionation of prions reveals a strain-specific continuum of quaternary structures with protease resistance developing at a hydrodynamic radius of 15 nm

Leonardo M. Cortez, Satish K. Nemani, Camilo Duque Velasquez, Aishwarya Sriraman, YongLiang Wang, Holger Wille, Debbie McKenzie, Valerie L. Sim

Summary: Researchers used a versatile fractionation technique to study the structural heterogeneity of prion strains, revealing that the quaternary structure of prion proteins is a major factor in this heterogeneity. They found that all studied strains underwent significant structural changes resulting in two distinct subpopulations, correlated with strain phenotype. The work provides new insights into the molecular basis of prion strain variation and demonstrates the potential application to other protein misfolding neurodegenerative disorders.

PLOS PATHOGENS (2021)

Article Biochemistry & Molecular Biology

Probing the origin of prion protein misfolding via reconstruction of ancestral proteins

Leonardo M. Cortez, Anneliese J. Morrison, Craig R. Garen, Sawyer Patterson, Toshi Uyesugi, Rafayel Petrosyan, Rohith Vedhthaanth Sekar, Michael J. Harms, Michael T. Woodside, Valerie L. Sim

Summary: Prion diseases are caused by the misfolding of the prion protein and can be fatal. This study reconstructed the sequences of ancestral PrP and found that the ability to form aggregates developed after the oldest common ancestor. The aggregation capabilities diverged along evolutionary pathways consistent with the susceptibilities seen in modern-day species. The research suggests that susceptibility to prion disease emerged prior to approximately 100 million years ago, with placental mammals possibly being generally susceptible.

PROTEIN SCIENCE (2022)

Article Immunology

Mast Cell Proteases Cleave Prion Proteins and a Recombinant Ig against PrP Can Activate Human Mast Cells

Steven D. Willows, Valentyna Semenchenko, Grant Norman, Michael T. Woodside, Valerie L. Sim, Marianna Kulka

Summary: IgE antibodies, although primarily associated with allergic reactions, have the potential to be an alternative to commonly used IgGs in immunotherapies. The affinity of IgE antigen binding affects the response from mast cells, so any IgE-based immunotherapies must carefully consider the balance between antigen affinity and therapeutic effect.

JOURNAL OF IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis

Lan Ye, Jay Rasmussen, Stephan A. Kaeser, Anne-Marie Marzesco, Ulrike Obermueller, Jasmin Mahler, Juliane Schelle, Joerg Odenthal, Christian Krueger, Sarah K. Fritschi, Lary C. Walker, Matthias Staufenbiel, Frank Baumann, Mathias Jucker

EMBO REPORTS (2017)

No Data Available